Study of Long Term Immune Responses and Safety of the GSK Herpes Zoster Vaccine in Healthy Subjects

NCT01295320 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
129
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

GlaxoSmithKline